Generally, BC in the elderly population is considered to have a better clinical presentation regarding receptor status [human epidermal receptor2 (HER2) expression], grade, lymph node involvement, and tumor size [4, 5]; however, some studies have shown that older individuals are diagnosed at later stages [6]. This evidence concerns the gene ERBB2 and neoplasm.